You are here

AstraZeneca

AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment

Pharmaforum

Wed, 08/14/19 - 11:01 am

clinical trials

advanced ovarian cancer

AstraZeneca Success On Prostate Cancer Drug Lowers Enthusiasm For Clovis

Yahoo/Benzinga

Wed, 08/14/19 - 10:13 am

Clovis Oncology

prostate cancer

AstraZeneca cancer drugs build as primary care shrinks

Biopharma Dive

Mon, 08/12/19 - 12:08 pm

AstraZeneca's flagship Tagrisso helps lung cancer patients live longer in pivotal study

Endpoints

Fri, 08/9/19 - 10:28 am

EGFR-mutated NSCLC

Clovis investors feel more Lynparza pressure

EP Vantage

Thu, 08/8/19 - 10:51 am

prostate cancer

Clovis Oncology

3 Lung Cancer Stocks That Could Soar in September

Motley Fool

Mon, 08/5/19 - 12:04 am

AstraZeneca raises sales forecast after second-quarter cancer drug, China boost

Yahoo/Reuters

Thu, 07/25/19 - 10:33 am

AstraZeneca to shell out £12M in severance dispute with workers at former England plant

Fierce Pharma

Thu, 07/18/19 - 12:00 pm

Exclusive interview with AstraZeneca ahead of upcoming Wearable Injectors & Connected Devices

Pharmaforum

Wed, 07/17/19 - 09:48 am

AstraZeneca’s Imfinzi gets FDA orphan drug status for small cell lung cancer

Pharmaceutical Business Review

Tue, 07/16/19 - 10:59 am

small cell lung cancer

AstraZeneca's Farxiga fails to get U.S. approval for Type-1 diabetes

Yahoo/Reuters

Mon, 07/15/19 - 09:58 am

type 1 diabetes

NICE recommends funding for psoriasis and type 1 diabetes drugs

Pharmaforum

Fri, 07/12/19 - 12:14 pm

Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs

Xconomy

Thu, 07/11/19 - 11:15 pm

Alzheimer's disease

BACE inhibitors

AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition

BioSpace

Thu, 06/27/19 - 06:38 pm

clinical trials

extensive-stage small cell lung cancer

AZ’s Imfinzi on target in small cell lung cancer, sets up Roche rivalry

Pharmaforum

Thu, 06/27/19 - 09:34 am

extensive-stage small cell lung cancer

Abbvie proves the best at getting the most out of its workers

EP Vantage

Fri, 06/21/19 - 09:44 am

Bristol-Myers Squibb

revenue per employee

AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment

Yahoo/Reuters

Tue, 06/18/19 - 10:04 am

AstraZeneca's Calquence sets Imbruvica in its sights with big CLL survival numbers

Fierce Pharma

Mon, 06/17/19 - 11:21 pm

AstraZeneca spinout Viela Bio pockets $75M on its way to BLA for autoimmune drug

Endpoints

Mon, 06/17/19 - 12:21 pm

autoimmune disease

AstraZeneca commits $630M to Korean drug R&D push

Fierce Biotech

Mon, 06/17/19 - 09:58 am

Pages